Current stock page

Financial Data

HOLX Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Instruments & SuppliesScore data as of Sep 6, 2026

HOLX

Financial Data
Hologic, Inc.
Healthcare· Medical - Instruments & Supplies
AIQ Score
NeutralAIQ Edge 6/10
Low Priority
Above Peers
Score data as of Sep 6, 2026
Last price
Latest market quote
Momentum
Value37
Quality58
Risk Resilience81
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 6, 2026.

Income statement
8 periods
Metric2025-12-272025-09-272025-06-282025-03-292024-12-282024-09-302024-06-292024-03-30
Revenue$1.05B$1.05B$1.02B$1.01B$1.02B$988M$1.01B$1.02B
Gross Profit$586.4M$639.1M$576.6M$377.3M$580.5M$557.7M$560.3M$562.5M
Operating Income
Net Income$179.1M$187.3M$194.9M-$17.4M$201M$178.6M$194.5M$169.9M
EPS$0.8$0.84$0.87-$0.08$0.87$0.76$0.83$0.72
Cash flow statement
8 periods
Metric2025-12-272025-09-272025-06-282025-03-292024-12-282024-09-302024-06-292024-03-30
Operating Cash Flow$229.9M$355.1M$343.3M$169.4M$189.3M$367M$405.8M$292.4M
Capital Expenditure-$14.7M-$30.4M-$12.8M-$40.2M-$47M-$30.3M-$33.9M-$28M
Free Cash Flow$215.2M$324.7M$330.5M$129.2M$142.3M$336.7M$371.9M$264.4M
Net Cash Provided By Operating Activities$229.9M$355.1M$343.3M$169.4M$189.3M$367M$405.8M$292.4M
Balance sheet
8 periods
Metric2025-12-272025-09-272025-06-282025-03-292024-12-282024-09-302024-06-292024-03-30
Total Assets$9.18B$9.01B$8.81B$8.55B$8.73B$9.16B$8.89B$8.71B
Total Debt$2.52B$2.63B$2.52B$2.53B$2.54B$2.66B$2.56B$2.57B
Cash And Cash Equivalents
Total Liabilities$3.94B$3.97B$3.96B$3.93B$3.96B$4.03B$3.94B$3.87B
Total Stockholders Equity$5.25B$5.05B$4.84B$4.62B$4.77B$5.13B$4.95B$4.84B
Key financial metrics
8 periods
Metric2025-12-272025-09-272025-06-282025-03-292024-12-282024-09-302024-06-292024-03-30
P/E ratio23.3420.2418.71-198.9120.7926.6622.3927.06
P/B ratio3.1933.0133.53.713.523.8
P/S ratio15.9614.4514.2413.7716.3619.2717.2218.07
Debt To Equity0.480.520.520.550.530.520.520.53
Free Cash Flow Yield
Financial ratios
8 periods
Metric2025-12-272025-09-272025-06-282025-03-292024-12-282024-09-302024-06-292024-03-30
P/E ratio
P/B ratio3.1933.0133.53.713.523.8
P/S ratio15.9614.4514.2413.7716.3619.2717.2218.07
Return On Equity3.41%3.71%4.02%-0.38%4.21%3.48%3.93%3.51%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
31.28
multipleSep 5, 2026
Pb
3.25
multipleSep 5, 2026
Revenue Growth Yoy
-0.16
percentSep 5, 2026
EPS Growth Yoy
-4.76
percentSep 5, 2026
Gross Margin
52.82
percentSep 5, 2026
Operating Margin
17.49
percentSep 5, 2026
ROE
11.01
percentSep 5, 2026
ROIC
7.18
percentSep 5, 2026
Debt To Equity
0.48
ratioSep 5, 2026
FCF Yield
5.89
percentSep 5, 2026
Technical indicators
Close
76.01
priceApr 6, 2026
Volume
102,025,619
volumeApr 6, 2026
Rsi14
77.22
indexApr 6, 2026
MACD
0.13
indexApr 6, 2026
MACD Signal
0.1
indexApr 6, 2026
MACD Histogram
0.03
indexApr 6, 2026
Adx14
18.6
indexApr 6, 2026
Sma50
75.29
priceApr 6, 2026
Sma200
71.23
priceApr 6, 2026
Atr14
0.23
priceApr 6, 2026
Historical Volatility
0.03
percentApr 6, 2026
Volume Ma20
8,257,895.6
volumeApr 6, 2026
Risk measures
Resilience Score
81
score_0_100Sep 5, 2026
Beta
0.7
ratioSep 5, 2026
Volatility Annual
15.99
percentSep 5, 2026
Max Drawdown
-8.19
percentSep 5, 2026
Sharpe Ratio
0.99
ratioSep 5, 2026
Var95
-1.32
percentSep 5, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

HOLX Financial Data FAQ

What is Hologic, Inc.'s revenue?

Hologic, Inc.'s revenue is one of the core financial data points for HOLX. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Hologic, Inc.'s revenue growing?

Revenue growth shows whether Hologic, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is HOLX's EPS?

HOLX's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Hologic, Inc.'s net income?

Hologic, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Hologic, Inc. generate?

Free cash flow shows how much cash Hologic, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Hologic, Inc. have?

Cash and debt help frame HOLX's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.